180 related articles for article (PubMed ID: 147811)
1. Degradation of human fibrinogen by plasmin: isolation and partial characterization of an early degradation product.
Regañon E; Aznar J; Vila V
Haemostasis; 1978; 7(1):26-34. PubMed ID: 147811
[TBL] [Abstract][Full Text] [Related]
2. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
Alkjaersig N; Davies A; Fletcher A
Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
[TBL] [Abstract][Full Text] [Related]
3. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
4. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
5. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
[TBL] [Abstract][Full Text] [Related]
7. A subfraction of fragment D isolated from a plasmin hydrolysate of human fibrinogen.
Hörmann H
Hoppe Seylers Z Physiol Chem; 1975 Dec; 356(12):1947-53. PubMed ID: 129428
[TBL] [Abstract][Full Text] [Related]
8. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
[TBL] [Abstract][Full Text] [Related]
9. Degradation of fibrinogen and fibrin by plasmin and nonplasmin proteases in the chronic subdural hematoma: evaluation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot.
Nomura S; Kashiwagi S; Ito H; Mimura Y; Nakamura K
Electrophoresis; 1993 Dec; 14(12):1318-21. PubMed ID: 8137796
[TBL] [Abstract][Full Text] [Related]
10. A simple and practical method for isolation of an early plasmin degradation product of human fibrinogen.
Takagi K; Kawai T
Thromb Haemost; 1977 Jun; 37(3):464-70. PubMed ID: 142313
[TBL] [Abstract][Full Text] [Related]
11. Unreliability in the estimation of the molecular weight of fibrinogen degradation products (FDPs) by polyacrylamide/sodium dodecyl sulphate electrophoresis (SDS/PAGE).
Arocha-Piñango CL; Perales J; Carvajal Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):737-41. PubMed ID: 2416650
[TBL] [Abstract][Full Text] [Related]
12. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
Marder VJ; Budzynski AZ; Barlow GH
Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
[TBL] [Abstract][Full Text] [Related]
14. Plasmic degradation of human fibrinogen. III. Molecular model of the plasmin-resistant disulfide knot in monomeric fragment D.
Furlan M; Kemp G; Beck EA
Biochim Biophys Acta; 1975 Jul; 400(1):95-111. PubMed ID: 125109
[TBL] [Abstract][Full Text] [Related]
15. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
[TBL] [Abstract][Full Text] [Related]
16. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
Stegnar M; Chen JP
Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
Dang CV; Bell WR; Ebert RF; Starksen NF
Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
[TBL] [Abstract][Full Text] [Related]
18. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
Sato H; Swadesh JK
Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
[TBL] [Abstract][Full Text] [Related]
19. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.
Olexa SA; Budzynski AZ
J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698
[TBL] [Abstract][Full Text] [Related]
20. Fractionation of plasmic fibrinogen digest on lysine-agarose. Isolation of two fragments D, fragment E and simultaneous removal of plasmin.
Rupp C; Sievi R; Furlan M
Thromb Res; 1982 Jul; 27(1):117-21. PubMed ID: 6214865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
